Hostname: page-component-6766d58669-h8lrw Total loading time: 0 Render date: 2026-05-17T07:57:53.261Z Has data issue: false hasContentIssue false

Providing free heroin to addicts participating in research – ethical concerns and the question of voluntariness

Published online by Cambridge University Press:  02 January 2018

Edmund Henden*
Affiliation:
Oslo and Akershus University College of Applied Sciences, Norway
Kristine Bærøe
Affiliation:
University of Bergen, Norway
*
Correspondence to Edmund Henden (edmund.henden@hioa.no)
Rights & Permissions [Opens in a new window]

Summary

Providing heroin to people with heroin addiction taking part in medical trials assessing the effectiveness of the drug as a treatment alternative breaches ethical research standards, some ethicists maintain. Heroin addicts, they say, are unable to consent voluntarily to taking part in these trials. Other ethicists disagree. In our view, both sides of the debate have an inadequate understanding of ‘voluntariness’. In this article we therefore offer a fuller definition of the concept, one which allows for a more flexible, case-to-case approach in which some heroin addicts are considered capable of consenting voluntarily, others not. An advantage of this approach, it is argued, is that it provides a safety net to minimise the risk of inflicting harm on trial participants.

Information

Type
Special Articles
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an open-access article published by the Royal College of Psychiatrists and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © 2014 The Authors
Submit a response

eLetters

No eLetters have been published for this article.